<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN"
        "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article  article-type="research-article"        dtd-version="1.4">
            <front>

                <journal-meta>
                                                                <journal-id>mersin univ saglık bilim derg</journal-id>
            <journal-title-group>
                                                                                    <journal-title>Mersin Üniversitesi Sağlık Bilimleri Dergisi</journal-title>
            </journal-title-group>
                                        <issn pub-type="epub">1308-0830</issn>
                                                                                            <publisher>
                    <publisher-name>Mersin University</publisher-name>
                </publisher>
                    </journal-meta>
                <article-meta>
                                        <article-id pub-id-type="doi">10.26559/mersinsbd.1145014</article-id>
                                                                <article-categories>
                                            <subj-group  xml:lang="en">
                                                            <subject>Health Care Administration</subject>
                                                    </subj-group>
                                            <subj-group  xml:lang="tr">
                                                            <subject>Sağlık Kurumları Yönetimi</subject>
                                                    </subj-group>
                                    </article-categories>
                                                                                                                                                        <title-group>
                                                                                                                        <trans-title-group xml:lang="en">
                                    <trans-title>Retrospective evaluation of epidemiological, clinical and Real-time PCR cycle threshold of SARS-CoV-2 infection positive pediatric patients</trans-title>
                                </trans-title-group>
                                                                                                                                                                                                <article-title>SARS-CoV-2 enfeksiyonu pozitif çocuk hastaların gerçek zamanlı PCR döngü eşik değeri, epidemiyolojik ve klinik özelliklerinin retrospektif olarak değerlendirilmesi</article-title>
                                                                                                    </title-group>
            
                                                    <contrib-group content-type="authors">
                                                                        <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0002-4154-8596</contrib-id>
                                                                <name>
                                    <surname>Bayram</surname>
                                    <given-names>Gül</given-names>
                                </name>
                                                                    <aff>MERSİN ÜNİVERSİTESİ, SAĞLIK HİZMETLERİ MESLEK YÜKSEKOKULU</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0003-3199-3132</contrib-id>
                                                                <name>
                                    <surname>Gülbudak</surname>
                                    <given-names>Harun</given-names>
                                </name>
                                                                    <aff>MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, TEMEL TIP BİLİMLERİ BÖLÜMÜ, TIBBİ MİKROBİYOLOJİ ANABİLİM DALI</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0002-7094-4838</contrib-id>
                                                                <name>
                                    <surname>Bozok</surname>
                                    <given-names>Taylan</given-names>
                                </name>
                                                                    <aff>MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, TEMEL TIP BİLİMLERİ BÖLÜMÜ, TIBBİ MİKROBİYOLOJİ ANABİLİM DALI</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0002-6397-2320</contrib-id>
                                                                <name>
                                    <surname>Akça</surname>
                                    <given-names>Mehtap</given-names>
                                </name>
                                                                    <aff>MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, ÇOCUK SAĞLIĞI VE HASTALIKLARI ANABİLİM DALI, ÇOCUK ENFEKSİYON HASTALIKLARI BİLİM DALI</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0002-0227-5273</contrib-id>
                                                                <name>
                                    <surname>Çiftçi</surname>
                                    <given-names>Ali Türker</given-names>
                                </name>
                                                                    <aff>MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, TEMEL TIP BİLİMLERİ BÖLÜMÜ, BİYOİSTATİSTİK VE TIBBİ BİLİŞİM ANABİLİM DALI</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0002-6721-4105</contrib-id>
                                                                <name>
                                    <surname>Kuyucu</surname>
                                    <given-names>Necdet</given-names>
                                </name>
                                                                    <aff>MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, ÇOCUK SAĞLIĞI VE HASTALIKLARI ANABİLİM DALI</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0002-1221-7907</contrib-id>
                                                                <name>
                                    <surname>Aslan</surname>
                                    <given-names>Gönül</given-names>
                                </name>
                                                                    <aff>MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ, TEMEL TIP BİLİMLERİ BÖLÜMÜ, TIBBİ MİKROBİYOLOJİ ANABİLİM DALI</aff>
                                                            </contrib>
                                                                                </contrib-group>
                        
                                        <pub-date pub-type="pub" iso-8601-date="20221231">
                    <day>12</day>
                    <month>31</month>
                    <year>2022</year>
                </pub-date>
                                        <volume>15</volume>
                                        <issue>3</issue>
                                        <fpage>561</fpage>
                                        <lpage>572</lpage>
                        
                        <history>
                                    <date date-type="received" iso-8601-date="20220720">
                        <day>07</day>
                        <month>20</month>
                        <year>2022</year>
                    </date>
                                                    <date date-type="accepted" iso-8601-date="20220908">
                        <day>09</day>
                        <month>08</month>
                        <year>2022</year>
                    </date>
                            </history>
                                        <permissions>
                    <copyright-statement>Copyright © 2008, Mersin Üniversitesi Sağlık Bilimleri Dergisi</copyright-statement>
                    <copyright-year>2008</copyright-year>
                    <copyright-holder>Mersin Üniversitesi Sağlık Bilimleri Dergisi</copyright-holder>
                </permissions>
            
                                                                                                <trans-abstract xml:lang="en">
                            <p>Aim: Risk factors that cause severe clinical outcomes caused by COVID-19 are better defined in adult patients than in the pediatric patient group. In this study, it was aimed to evaluate the relationship between socio-demographic characteristics, clinical findings and cycle threshold (Ct) value in pediatric patients who applied to our hospital with the suspicion of COVID-19 and were found to have a positive SARS-CoV-2 test. Method: In the study, 2971 pediatric patients with positive SARS-CoV-2 RT-qPCR test in Mersin University Hospital COVID-19 laboratory between 1 May 2020 and 31 October 2021 were included in the study. The SARS-CoV-2 RT-qPCR test was performed on nasopharyngeal and oropharyngeal swab samples. Ct values obtained from the RT-qPCR result were classified as low, moderate, and high. Results: The most common symptoms in pediatric patients with positive SARS-CoV-2 infection were fever 41.5%, cough 28.6% and sore throat 24.4%, respectively. Ct values of SARS-CoV-2 positive asymptomatic and symptomatic pediatric patients are low (&amp;lt;24) and the patients are in the high risk group. When the relationship between symptoms and Ct groups in SARS-CoV-2 positive children was evaluated, it was determined that patients with fever (43.1%), fatigue (18.8%) and headache (16.3%) were in the high viral load group. Conclusion: Most of the contact patients in our study were thought to have low Ct value because they were exposed to a family member with COVID-19. Therefore, monitoring, control and isolation of this contact group with high potential contagion is an important point in terms of public health.</p></trans-abstract>
                                                                                                                                    <abstract><p>Amaç: COVID-19’un yol açtığı şiddetli klinik sonuçlara neden olan risk faktörleri yetişkin hastalarda çocuk hasta grubuna göre daha iyi tanımlanmıştır. Bu çalışmada hastanemize COVID-19 şüphesi ile başvuran ve SARS-CoV-2 testi pozitif saptanan çocuk hastalarda sosyo-demogrofik özellikler, klinik bulgular ve eşik değeri “cycle threshold” (Ct) değeri arasındaki ilişkinin değerlendirilmesi amaçlanmıştır. Yöntem: Çalışmada 1 Mayıs 2020-31 Ekim 2021 tarihleri arasında Mersin Üniversitesi Hastanesi COVID-19 laboratuvarında SARS-CoV-2 RT-qPCR testi pozitif saptanan 2971 çocuk hasta çalışmaya dahil edilmiştir. SARS-CoV-2 RT-qPCR testi, nazofarengeal ve orofarengeal sürüntü örneklerinden yapılmıştır. RT-qPCR sonucundan elde edilen Ct değerleri düşük, orta, yüksek şeklinde sınıflandırılmıştır. Bulgular: SARS-CoV-2 enfeksiyonu pozitif olan çocuk hastalarda en sık görülen semptomlar sırasıyla ateş %41.5, öksürük %28.6 ve boğaz ağrısı %24.4 olarak belirlenmiştir. SARS-CoV-2 pozitif asemptomatik ve semptomatik çocuk hastaların Ct değerleri düşüktür (&amp;lt;24) ve hastalar yüksek risk grubunda yer almaktadır. SARS-CoV-2 pozitif çocuklarda semptomlar ve Ct grupları arasındaki ilişki değerlendirildiğinde özellikle ateş (%43.1), halsizlik (%18.8) ve baş ağrısı (%16.3) semptomu gösteren hastaların yüksek viral yük grubunda olduğu saptanmıştır.  Sonuç: Çalışmamızda yer alan temaslı hastaların çoğunun COVID-19’lu aile üyelerinden birine maruz kalması nedeniyle Ct değerinin düşük olduğu düşünülmektedir. Bundan dolayı potansiyel bulaştırıcılıkları yüksek olan bu temaslı grubunun takibi, kontrolü ve izolasyonu halk sağlığı açısından önemli bir noktadır.</p></abstract>
                                                            
            
                                                                                        <kwd-group>
                                                    <kwd>SARS-CoV-2</kwd>
                                                    <kwd>  COVID-19</kwd>
                                                    <kwd>  eşik değeri (Ct)</kwd>
                                                    <kwd>  semptom</kwd>
                                            </kwd-group>
                            
                                                <kwd-group xml:lang="en">
                                                    <kwd>SARS-CoV-2</kwd>
                                                    <kwd>  COVID-19</kwd>
                                                    <kwd>  cycle threshold (Ct)</kwd>
                                                    <kwd>  symptom</kwd>
                                            </kwd-group>
                                                                                                                                    <funding-group specific-use="FundRef">
                    <award-group>
                                                    <funding-source>
                                <named-content content-type="funder_name">Yok</named-content>
                            </funding-source>
                                                                            <award-id>Yok</award-id>
                                            </award-group>
                </funding-group>
                                </article-meta>
    </front>
    <back>
                            <ref-list>
                                    <ref id="ref1">
                        <label>1</label>
                        <mixed-citation publication-type="journal">World Health Organization. https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/novel-coronavirus-2019-ncov. 9 Nisan 2022’ de erişildi.</mixed-citation>
                    </ref>
                                    <ref id="ref2">
                        <label>2</label>
                        <mixed-citation publication-type="journal">World Health Organization. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. 19 Nisan 2022’ de erişildi.</mixed-citation>
                    </ref>
                                    <ref id="ref3">
                        <label>3</label>
                        <mixed-citation publication-type="journal">World Health Organization. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---22-june-2022. 23 Haziran 2022’ de erişildi.</mixed-citation>
                    </ref>
                                    <ref id="ref4">
                        <label>4</label>
                        <mixed-citation publication-type="journal">Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: An overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020;39(5):355-68. doi: 10.1097/INF.0000000000002660.</mixed-citation>
                    </ref>
                                    <ref id="ref5">
                        <label>5</label>
                        <mixed-citation publication-type="journal">Centers for Disease Control and Prevention. https://www.cdc.gov/mmwr/volumes/71/wr/mm7111e2.htm. 22 Mart 2022’ de erişildi.</mixed-citation>
                    </ref>
                                    <ref id="ref6">
                        <label>6</label>
                        <mixed-citation publication-type="journal">Wald ER, Schmit KM, Gusland DY. A Pediatric infectious disease perspective on COVID-19. Clin Infect Dis. 2021;72(9):1660-66. doi: 10.1093/cid/ciaa1095.</mixed-citation>
                    </ref>
                                    <ref id="ref7">
                        <label>7</label>
                        <mixed-citation publication-type="journal">Maltezou HC, Magaziotou I, Dedoukou X, et al. Children and adolescents with SARS-CoV-2 infection: Epidemiology, clinical course and viral loads. Pediatr Infect Dis J. 2020;39(12):e388-e392. doi: 10.1097/INF.0000000000002899.</mixed-citation>
                    </ref>
                                    <ref id="ref8">
                        <label>8</label>
                        <mixed-citation publication-type="journal">Afonso ET, Marques SM, Costa LDC, et al. Secondary household transmission of SARS-CoV-2 among children and adolescents: Clinical and epidemiological aspects. Pediatr Pulmonol. 2022;57(1):162-175. doi: 10.1002/ppul.25711.</mixed-citation>
                    </ref>
                                    <ref id="ref9">
                        <label>9</label>
                        <mixed-citation publication-type="journal">Yung CF, Kam KQ, Chong CY, et al. Household transmission of Severe Acute Respiratory Syndrome Coronavirus 2 from adults to children. J Pediatr. 2020;225:249-51. doi: 10.1016/j.jpeds.2020.07.009.</mixed-citation>
                    </ref>
                                    <ref id="ref10">
                        <label>10</label>
                        <mixed-citation publication-type="journal">Dus-Ilnicka I, Szymczak A, Malodobra-Mazur M, Tokarski M. Role of laboratory medicine in SARS-CoV-2 diagnostics. lessons learned from a pandemic. Healthcare. 2021;9(7):915. doi: 10.3390/healthcare9070915.</mixed-citation>
                    </ref>
                                    <ref id="ref11">
                        <label>11</label>
                        <mixed-citation publication-type="journal">Moreno-Contreras J, Espinoza MA, Sandoval-Jaime C, et al. Saliva sampling and its direct lysis, an excellent option to increase the number of SARS-CoV-2 diagnostic tests in settings with supply shortages. J Clin Microbiol. 2020;58(10): e01659-20. doi: 10.1128/JCM.01659-20.</mixed-citation>
                    </ref>
                                    <ref id="ref12">
                        <label>12</label>
                        <mixed-citation publication-type="journal">Yuan X,  Yang C,  He Q,, et al. Current and perspective diagnostic techniques for COVID-19. ACS Infect Dis. 2020;6(8):1998–2016. doi: 10.1016/j.jpeds.2020.07.009.</mixed-citation>
                    </ref>
                                    <ref id="ref13">
                        <label>13</label>
                        <mixed-citation publication-type="journal">Rao SN, Manissero D, Steele VR, Pareja J. A Narrative systematic review of the clinical utility of cycle threshold values in the context of COVID-19. Infect Dis Ther. 2020; 9:573-86. doi: 10.1007/s40121-020-00324-3.</mixed-citation>
                    </ref>
                                    <ref id="ref14">
                        <label>14</label>
                        <mixed-citation publication-type="journal">Tom MR, Mina, MJ. To interpret the SARS-CoV-2 test, consider the cycle threshold value. Clin Infect Dis. 2020:71(16):2252–54. doi: 10.1093/cid/ciaa619.</mixed-citation>
                    </ref>
                                    <ref id="ref15">
                        <label>15</label>
                        <mixed-citation publication-type="journal">Aykac K, Yayla BCC, Ozsurekci Y, et al. The association of viral load and disease severity in children with COVID-19. J Med Virol. 2021;93(5):3077-83. doi: 10.1002/jmv.26853.</mixed-citation>
                    </ref>
                                    <ref id="ref16">
                        <label>16</label>
                        <mixed-citation publication-type="journal">Sarkar B, Sinha RN, Sarkar K. Initial viral load of a COVID19-infected case indicated by its cycle threshold value of polymerase chain reaction could be used as a predictor of its transmissibility-an experience from Gujarat, India. Indian J Community Med. 2020;45(3):278–282. doi: 10.4103/ijcm.IJCM_593_20.</mixed-citation>
                    </ref>
                                    <ref id="ref17">
                        <label>17</label>
                        <mixed-citation publication-type="journal">La Scola B, Le Bideau M, Andreani J, et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis. 2020; 39:1059-61. doi: 0.1007/s10096-020-03913-9.</mixed-citation>
                    </ref>
                                    <ref id="ref18">
                        <label>18</label>
                        <mixed-citation publication-type="journal">Centers for Disease Control and Prevention. Symptoms of COVID-19 https://www.cdc.gov/coronavirus/2019-ncov/ symptoms-testing/symptoms.html. 4 Mart 2022’de erişildi.</mixed-citation>
                    </ref>
                                    <ref id="ref19">
                        <label>19</label>
                        <mixed-citation publication-type="journal">Bai Y, Gao L, Wang X, et al. Epidemiological characteristics and clinical manifestations of pediatric patients with COVID-19 in China: A multicenter retrospective study. Pediatr Investig. 2021:12;5(3):e12282. doi: 10.1002/ped4.12282.</mixed-citation>
                    </ref>
                                    <ref id="ref20">
                        <label>20</label>
                        <mixed-citation publication-type="journal">Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088-95. doi: 10.1111/apa.15270.</mixed-citation>
                    </ref>
                                    <ref id="ref21">
                        <label>21</label>
                        <mixed-citation publication-type="journal">Berksoy E, Kanik A, Çiçek A, et al. Clinical and laboratory characteristics of children with SARS-CoV-2 infection. Pediatr Pulmonol. 2021;56(12):3674-81. doi: 10.1002/ppul.25654.</mixed-citation>
                    </ref>
                                    <ref id="ref22">
                        <label>22</label>
                        <mixed-citation publication-type="journal">Şık N, Özlü C, Asrak HK, ve ark. Çocuk acil serviste SARS-CoV-2 PCR pozitif saptanan olguların değerlendirilmesi. Mikrobiyol Bul. 2020;54(4):629-637. doi:10.5578/mb.70086.</mixed-citation>
                    </ref>
                                    <ref id="ref23">
                        <label>23</label>
                        <mixed-citation publication-type="journal">Korkmaz MF, Türe E, Dorum BA, Kılıç ZB. The epidemiological and clinical characteristics of 81 children with COVID-19 in a pandemic hospital in Turkey: an observational cohort study. J Korean Med Sci. 2020;35(25):e236. doi: 10.3346/jkms.2020.35.e236.</mixed-citation>
                    </ref>
                                    <ref id="ref24">
                        <label>24</label>
                        <mixed-citation publication-type="journal">Özgökçe ÖB, Akça M, Bozlu G, Türkegün M, Kuyucu N. Covid 19 pandemisinin erken döneminde SARS-CoV-2 ile enfekte çocukların epidemiyolojik, klinik ve laboratuvar özelliklerinin değerlendirilmesi. Mersin Univ Saglık Bilim Derg. 2022; 15((Özel Sayı-1) 21. Mersin Pediatri Günleri Bildiri Kitabı): 157-169.</mixed-citation>
                    </ref>
                                    <ref id="ref25">
                        <label>25</label>
                        <mixed-citation publication-type="journal">Kociolek LK, Muller WJ, Yee R, et al. Comparison of upper respiratory viral load distributions in asymptomatic and symptomatic children diagnosed with SARS-CoV-2 infection in pediatric hospital testing programs. J Clin Microbiol. 2020;59(1):e02593-20. doi:10.1128/JCM.02593-20.</mixed-citation>
                    </ref>
                                    <ref id="ref26">
                        <label>26</label>
                        <mixed-citation publication-type="journal">Lyngse FP, Molbak K, Skov RL, et al. Increased transmissibility of SARS-CoV-2 lineage B.1.1.7 by age and viral load. Nat Commun. 2021;12(1):7251. doi: 10.1038/s41467-021-27202-x.</mixed-citation>
                    </ref>
                                    <ref id="ref27">
                        <label>27</label>
                        <mixed-citation publication-type="journal">Strutner J, Ramchandar N, Dubey S, et al. Comparison of RT-PCR cycle threshold values from respiratory specimens in symptomatic and asymptomatic children with SARS-CoV-2 infection. Clin Infect Dis. 2021:ciab403. doi: 10.1093/cid/ciab403.</mixed-citation>
                    </ref>
                                    <ref id="ref28">
                        <label>28</label>
                        <mixed-citation publication-type="journal">Kam KQ, Thoon KC, Maiwald M, et al. SARS-CoV-2 viral RNA load dynamics in the nasopharynx of infected children. Epidemiol Infect. 2021;149:e18. 10.1017/S095026882100008X.</mixed-citation>
                    </ref>
                                    <ref id="ref29">
                        <label>29</label>
                        <mixed-citation publication-type="journal">Yonker LM, Neilan AM, Bartsch Y, et al. Pediatric severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2): Clinical presentation, infectivity, and immune responses. J Pediatr. 2020;227:45-52.e5. 10.1016/j.jpeds.2020.08.037.</mixed-citation>
                    </ref>
                                    <ref id="ref30">
                        <label>30</label>
                        <mixed-citation publication-type="journal">Chakraborty C, Sharma AR, Bhattacharya M, Agoramoorthy G, Lee SS. A Paradigm shift in the combination changes of SARS-CoV-2 variants and increased spread of Delta variant (B.1.617.2) across the World. Aging Dis. 2022;13(3):927-942. doi:10.14336/AD.2021.1117.</mixed-citation>
                    </ref>
                            </ref-list>
                    </back>
    </article>
